Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Dow
Colorcon
Harvard Business School
McKesson

Last Updated: August 13, 2022

Investigational Drug Information for Ecgonine


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Ecgonine?

Ecgonine is an investigational drug.

There have been 5 clinical trials for Ecgonine. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2013.

The most common disease conditions in clinical trials are Cocaine-Related Disorders, Substance-Related Disorders, and Renal Insufficiency. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), Baylor College of Medicine, and Johns Hopkins University.

There are four hundred and two US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Ecgonine
TitleSponsorPhase
PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal FunctionCognitive Research CorporationPhase 1
PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal FunctionPharmaceutical Project Solutions, Inc.Phase 1
A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine AbuseIndivior Inc.Phase 2

See all Ecgonine clinical trials

Clinical Trial Summary for Ecgonine

Top disease conditions for Ecgonine
Top clinical trial sponsors for Ecgonine

See all Ecgonine clinical trials

US Patents for Ecgonine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ecgonine See Plans and Pricing Tamper-resistant pharmaceutical compositions of opioids and other drugs COLLEGIUM PHARMACEUTICAL, INC. (Canton, MA) See Plans and Pricing
Ecgonine See Plans and Pricing Pharmaceutical compositions and methods of using the same GENUS LIFESCIENCES INC. (Allentown, PA) See Plans and Pricing
Ecgonine See Plans and Pricing Topical film delivery system SIDMAK LABORATORIES (INDIA) PVT. LTD. (Valsad, Gujarat, IN) See Plans and Pricing
Ecgonine See Plans and Pricing Pharmaceutical compositions resistant to abuse EGALET LTD. (London, GB) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Ecgonine

Drugname Country Document Number Estimated Expiration Related US Patent
Ecgonine Australia AU2003247876 2022-07-05 See Plans and Pricing
Ecgonine Canada CA2491572 2022-07-05 See Plans and Pricing
Ecgonine Canada CA2569958 2022-07-05 See Plans and Pricing
Ecgonine Canada CA2916869 2022-07-05 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Dow
Colorcon
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.